Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  IDO inhibitor NLG919
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO29779, NCI-2015-02171, 2015-001741-88, NCT02471846
Start Over